Reinsurance Group of America Inc

Reinsurance Group of America Inc(RGA)股票分析

$266.750

+2.748 (+1.03%)收盘时

Loading chart…
最高
267.460
开盘
264.740
成交量加权均价
266.01
成交量
442.36K
市值
13.56B
最低
263.820
成交额
117.67M
企业价值/息税折旧摊销前利润(TTM)
5.88

Reinsurance Group of America, Incorporated is an insurance holding company. The Company is a provider of traditional life and health reinsurance and financial solutions. The U.S. and Latin America Traditional segment provides individual and group life and health reinsurance, including long-term care, to domestic clients for a variety of products. The Canada Traditional segment is primarily engaged in individual life reinsurance, and to a lesser extent creditor, group life and health, critical illness and disability reinsurance. The Europe, Middle East and Africa Traditional segment provides individual and group life and health products through yearly renewable term and coinsurance agreements, and reinsurance of critical illness coverage. The Asia Pacific Traditional segment provides individual and group life and health reinsurance, critical illness coverage, disability and superannuation through yearly renewable term and coinsurance agreements.

AI 分析 of Reinsurance Group of America Inc (RGA)

买入

Reinsurance Group of America Inc is a good buy right now due to its strong financial performance, including a recent EPS of $8.89 which exceeded expectations by $2.40, and a forward P/E ratio of 7.716, indicating potential for growth. Additionally, the stock has shown a 31.12% year-to-date change and a 41.56% increase over the past year, reflecting robust market demand. However, a risk to consider is the high RSI of 85.29, suggesting that the stock may be overbought in the short term.

分析师评级(9)

-9.15% 下跌空间
持有
2 买入
6 持有
1 卖出
当前: 266.75
最低
208.00
平均
242.33
最高
275.00

Barclays

2026-10-08

目标价

$292

增持

Barclays

2026-10-07

目标价

$286

增持

Morgan Stanley

2026-09-28

目标价

$295

增持

Morgan Stanley

2026-08-24

目标价

$250

Equal Weight

Wells Fargo

2026-08-19

目标价

$291

增持

估值指标

Reinsurance Group of America Inc(RGA)当前预期市盈率为 7.72,5 年平均预期市盈率为 8.86。

预期市盈率

合理
5 年均值 P/E
8.86
当前P/E
7.72
高估
10.95
低估
6.77

预期 EV/EBITDA

严重高估
5 年均值 EV/EBITDA
0.70
当前EV/EBITDA
5.88
高估
2.65
低估
-1.25

预期市销率

高估
5 年均值 P/S
0.53
当前P/S
0.61
高估
0.59
低估
0.47

Alphio AI 对 RGA 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%RGA

$214.60

情景价格

基

基准

基准 · 50%RGA

$208.51

情景价格

悲

悲观

悲观 · 25%RGA

$183.89

情景价格

持有 RGA 的大户

D

Douglas Lane & Associates, LLC

+ 持有RGA

+4.15%

3个月收益率

S

South Dakota Investment Council

+ 持有RGA

+4.10%

3个月收益率

L

Lighthouse Investment Partners, LLC

+ 持有RGA

+0.02%

3个月收益率

D

David Vaughan Investments, LLC

+ 持有RGA

-0.34%

3个月收益率

F

Freestone Grove Partners LP

+ 持有RGA

-1.44%

3个月收益率

W

WCM Investment Management

+ 持有RGA

-3.61%

3个月收益率

RGA 常见问题 —— 由 Alphio AI 解答

Reinsurance Group of America, Incorporated is an insurance holding company. The Company is a provider of traditional life and health reinsurance and financial solutions. The U.S. and Latin America Traditional segment provides individual and group life and health reinsurance, including long-term care, to domestic clients for a variety of products. The Canada Traditional segment is primarily engaged in individual life reinsurance, and to a lesser extent creditor, group life and health, critical illness and disability reinsurance. The Europe, Middle East and Africa Traditional segment provides individual and group life and health products through yearly renewable term and coinsurance agreements, and reinsurance of critical illness coverage. The Asia Pacific Traditional segment provides individual and group life and health reinsurance, critical illness coverage, disability and superannuation through yearly renewable term and coinsurance agreements. It operates in the Financials sector (LIFE INSURANCE industry).

Reinsurance Group of America Inc is a good buy right now due to its strong financial performance, including a recent EPS of $8.89 which exceeded expectations by $2.40, and a forward P/E ratio of 7.716, indicating potential for growth. Additionally, the stock has shown a 31.12% year-to-date change and a 41.56% increase over the past year, reflecting robust market demand. However, a risk to consider is the high RSI of 85.29, suggesting that the stock may be overbought in the short term.

9 analysts cover RGA: 2 rate it Buy, 6 Hold and 1 Sell. The average price target is 242.33.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易